Cumberland Pharmaceuticals (CPIX) Institutional Ownership → Have You Seen Elon’s New A.I. Device? (Picture Inside) (From InvestorPlace) (Ad) Free CPIX Stock Alerts $1.70 -0.07 (-3.69%) (As of 02:42 PM ET) Add Compare Share Share OwnershipStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Cumberland Pharmaceuticals (NASDAQ:CPIX)CurrentInstitutional OwnershipPercentage15.51%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$274.99KNumber ofInstitutional Sellers(last 12 months)0 Get CPIX Insider Trade Alerts Want to know when executives and insiders are buying or selling Cumberland Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CPIX Institutional Buying and Selling by Quarter Ad InvestorPlaceElon’s New A.I. Device is About to Shock the WorldUsing this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in… “The next step in human evolution.” Click here to see the details because there’s a lot of money at stake. Cumberland Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails10/24/2023 Bank of New York Mellon Corp75,268$142K0.0%N/A0.524% 7/27/2023B. Riley Wealth Advisors Inc.90,298$133K0.0%N/A0.625% 2/10/2023True Capital Management12,025$27K0.0%N/A0.082% 5/24/2022M Holdings Securities Inc.10,750$30K0.0%N/A0.073% 2/10/2022Acadian Asset Management LLC147,294$683K0.0%-9.2%0.995% 2/9/2022Dimensional Fund Advisors LP652,561$3.05M0.0%-6.3%4.406% Get the Latest News and Ratings for CPIX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cumberland Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 11/15/2021Berkshire Asset Management LLC PA176,185$472K0.0%+3.1%1.184% 11/15/2021Dimensional Fund Advisors LP696,654$1.88M0.0%-7.8%4.682% 11/12/2021Renaissance Technologies LLC664,564$1.78M0.0%-5.3%4.466% 11/9/2021BlackRock Inc.333,051$892K0.0%-15.9%2.238% 8/17/2021Berkshire Asset Management LLC PA170,830$486K0.0%+3.2%1.135% 8/13/2021Renaissance Technologies LLC701,463$2.00M0.0%-6.9%4.661% 8/13/2021California Public Employees Retirement System10,205$29K0.0%-79.3%0.068% 8/13/2021Ariel Investments LLC12,033$34K0.0%-94.3%0.080% 8/12/2021Dimensional Fund Advisors LP755,500$2.15M0.0%+2.4%5.020% 5/21/2021Citadel Advisors LLC17,005$52K0.0%N/A0.113% 5/18/2021Citadel Advisors LLC17,005$52K0.0%N/A0.114% 5/14/2021Arrowstreet Capital Limited Partnership10,700$32K0.0%N/A0.072% 5/14/2021Dimensional Fund Advisors LP737,881$2.24M0.0%-5.6%4.945% 5/13/2021Renaissance Technologies LLC753,053$2.28M0.0%+11.5%5.047% 5/12/2021M Holdings Securities Inc.10,750$33K0.0%N/A0.072% 5/11/2021Acadian Asset Management LLC175,015$529K0.0%+66.7%1.173% 3/8/2021Dimensional Fund Advisors LP781,891$2.30M0.0%-2.1%5.207% 2/25/2021Dimensional Fund Advisors LP781,891$2.30M0.0%-2.1%5.207% 2/12/2021Stonepine Capital Management LLC188,703$557K0.4%-68.0%1.257% 2/12/2021Ariel Investments LLC821,096$2.42M0.0%+4.9%5.468% 2/10/2021Renaissance Technologies LLC675,159$1.99M0.0%+12.6%4.496% 2/10/2021Sterling Financial Planning Inc.22,031$65K0.1%N/A0.147% 11/13/2020Stonepine Capital Management LLC589,497$1.89M2.0%-12.9%3.894% 11/6/2020BlackRock Inc.364,974$1.17M0.0%+2.1%2.411% 7/16/2020Wedbush Securities Inc.13,041$43K0.0%N/A0.086% 5/15/2020Morgan Stanley12,168$44K0.0%-20.5%0.080% 5/14/2020Stonepine Capital Management LLC907,735$3.30M3.5%+1.3%5.979% 5/11/2020Acadian Asset Management LLC92,643$335K0.0%-5.7%0.610% 5/1/2020BlackRock Inc.327,615$1.19M0.0%-1.2%2.158% (Data available from 1/1/2016 forward) CPIX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CPIX shares? During the previous two years, the following institutional investors and hedge funds held shares of Cumberland Pharmaceuticals shares: Bank of New York Mellon Corp ($142K), B. Riley Wealth Advisors Inc. ($133K), and M Holdings Securities Inc. ($30K), True Capital Management ($27K).Learn more on CPIX's institutional investors. What percentage of Cumberland Pharmaceuticals stock is owned by institutional investors? 15.51% of Cumberland Pharmaceuticals stock is owned by institutional investors. Learn more on CPIX's institutional investor holdings. Which institutional investors have been buying Cumberland Pharmaceuticals stock? The following institutional investors have purchased Cumberland Pharmaceuticals stock in the last 24 months: B. Riley Wealth Advisors Inc. ($90.30K), Bank of New York Mellon Corp ($75.27K), True Capital Management ($12.03K), and M Holdings Securities Inc. ($10.75K). How much institutional buying is happening at Cumberland Pharmaceuticals? Institutional investors have bought a total of 188,341 shares in the last 24 months. This purchase volume represents approximately $332.37K in transactions. Related Companies: ASMB Major Shareholders ONCT Major Shareholders BIOR Major Shareholders LUMO Major Shareholders SYBX Major Shareholders MEIP Major Shareholders LSTA Major Shareholders ENLV Major Shareholders TXMD Major Shareholders SNSE Major Shareholders This page (NASDAQ:CPIX) was last updated on 4/29/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe #1 Biotech Stock to Have on Your Radar in 2024… Huge AlertsAI finds its first serious applicationWall Street StarThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cumberland Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.